Search

everythinglearnresearchcommunity

for

Search:↓

Short-term treatment with ROCKi increases skin cell growth without changing stem cell features.

CI-1033 causes skin lesions in rats, similar to humans, due to EGF receptor inhibition.

Rapamycin reduces skin cell growth and tumor development by affecting cell signaling in mice.

Coinheritance of BRCA2 and CYLD genes may lead to new treatment options for certain cancers.

JAK inhibitors may become the first approved treatment for alopecia areata if they are proven safe and effective.

Suppressing ODC activity reduces tumor growth in hair follicles.

Janus Kinase Inhibitors are promising new treatments for various skin conditions due to their effectiveness and safety.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

c-Kit is important for heart regeneration and cancer development.

Primary care doctors need to monitor JAK and TYK-2 inhibitors carefully for skin conditions.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

Mice with extra PKCδ resist chemical-induced skin cancer but not UV-induced.

The topical inhibitor CUR61414 was not effective in treating basal cell carcinoma in human trials.

ATP-sensitive potassium channels are important for hair growth.

AD198 is more effective than doxorubicin in stopping certain dog cancer cells.

Alisertib was found to be an effective and tolerable treatment for children with recurrent brain tumors.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Antizyme slows skin tumor growth by reducing cell growth in mice.

PRIDE complex side effects from EGFR inhibitors can be managed without stopping treatment.

JAK inhibitors might help treat alopecia areata.

The treatment was ineffective in humans.

Lenvatinib and sorafenib are generally safe but need dose adjustments due to side effects.

Finasteride helps female-pattern hair loss.

Cancer prevention has advanced significantly, with some strategies proving successful.

Targeting multiple pathways and understanding genetic mutations are crucial for effective melanoma therapy.

Erlotinib causes skin inflammation through IL-1, which can be reduced by anakinra.

Early sunburn treatment with certain inhibitors may reduce skin cancer risk.

EGFR inhibitors can cause skin issues, but managing them is important for treatment success.